Chinese General Practice ›› 2024, Vol. 27 ›› Issue (14): 1685-1691.DOI: 10.12114/j.issn.1007-9572.2023.0569
• Article·Vertigo Section • Previous Articles Next Articles
Received:
2023-09-22
Revised:
2023-11-20
Published:
2024-05-15
Online:
2024-03-22
Contact:
YU Hong
通讯作者:
于红
作者简介:
基金资助:
关键词: 良性阵发性位置性眩晕, 前庭疾病, 残余症状, 心理因素, 影响因素分析
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0569
变量 | 原发组(n=184) | 继发组(n=156) | χ2(t)值 | P值 |
---|---|---|---|---|
性别[例(%)] | 0.40 | 0.53 | ||
男 | 67(36.4) | 62(39.7) | ||
女 | 117(63.6) | 94(60.3) | ||
发病年龄( | 52.8±6.1 | 50.9±6.2 | 2.95a | 0.03 |
受累半规管[例(%)] | 0.06 | 0.97 | ||
后 | 110(59.8) | 95(60.9) | ||
外 | 60(32.6) | 49(31.4) | ||
前 | 0 | 0 | ||
混合 | 14(7.6) | 12(7.7) | ||
复位次数[例(%)] | 14.37 | <0.01 | ||
≤2次 | 155(84.2) | 104(66.7) | ||
>2次 | 29(15.8) | 52(33.3) | ||
是否一次复位即成功[例(%)] | 34.92 | <0.01 | ||
是 | 137(74.5) | 67(42.9) | ||
否 | 47(25.5) | 89(57.1) | ||
3个月内是否复发[例(%)] | 18.882 | <0.01 | ||
是 | 10(5.4) | 33(21.2) | ||
否 | 174(94.6) | 123(78.8) | ||
复位后是否出现残余症状[例(%)] | 5.99 | 0.01 | ||
是 | 61(33.2) | 72(46.2) | ||
否 | 123(66.8) | 84(53.8) | ||
SAS评分( | ||||
诊断时 | 46.13±9.29 | 48.64±10.16 | 2.38a | 0.02 |
4周时 | 51.61±12.07 | 53.57±12.75 | 1.45a | 0.15 |
3个月时 | 47.60±11.831 | 48.45±13.27 | 0.62a | 0.54 |
SDS评分( | ||||
诊断时 | 50.38±9.84 | 53.03±12.11 | 2.19a | 0.03 |
4周时 | 54.39±12.73 | 56.41±14.50 | 1.36a | 0.18 |
3个月时 | 50.32±11.66 | 51.53±12.11 | 0.94a | 0.35 |
Table 1 Comparison of clinical features between the primary group and secondary group
变量 | 原发组(n=184) | 继发组(n=156) | χ2(t)值 | P值 |
---|---|---|---|---|
性别[例(%)] | 0.40 | 0.53 | ||
男 | 67(36.4) | 62(39.7) | ||
女 | 117(63.6) | 94(60.3) | ||
发病年龄( | 52.8±6.1 | 50.9±6.2 | 2.95a | 0.03 |
受累半规管[例(%)] | 0.06 | 0.97 | ||
后 | 110(59.8) | 95(60.9) | ||
外 | 60(32.6) | 49(31.4) | ||
前 | 0 | 0 | ||
混合 | 14(7.6) | 12(7.7) | ||
复位次数[例(%)] | 14.37 | <0.01 | ||
≤2次 | 155(84.2) | 104(66.7) | ||
>2次 | 29(15.8) | 52(33.3) | ||
是否一次复位即成功[例(%)] | 34.92 | <0.01 | ||
是 | 137(74.5) | 67(42.9) | ||
否 | 47(25.5) | 89(57.1) | ||
3个月内是否复发[例(%)] | 18.882 | <0.01 | ||
是 | 10(5.4) | 33(21.2) | ||
否 | 174(94.6) | 123(78.8) | ||
复位后是否出现残余症状[例(%)] | 5.99 | 0.01 | ||
是 | 61(33.2) | 72(46.2) | ||
否 | 123(66.8) | 84(53.8) | ||
SAS评分( | ||||
诊断时 | 46.13±9.29 | 48.64±10.16 | 2.38a | 0.02 |
4周时 | 51.61±12.07 | 53.57±12.75 | 1.45a | 0.15 |
3个月时 | 47.60±11.831 | 48.45±13.27 | 0.62a | 0.54 |
SDS评分( | ||||
诊断时 | 50.38±9.84 | 53.03±12.11 | 2.19a | 0.03 |
4周时 | 54.39±12.73 | 56.41±14.50 | 1.36a | 0.18 |
3个月时 | 50.32±11.66 | 51.53±12.11 | 0.94a | 0.35 |
变量 | SSNHL(n=39) | VM(n=37) | MD(n=38) | VN(n=27) | 其他(n=15) | χ2(F)值 | P值 |
---|---|---|---|---|---|---|---|
性别[例(%)] | 1.96 | 0.74 | |||||
男 | 15(38.5) | 14(37.8) | 13(34.2) | 12(44.4) | 8(53.3) | ||
女 | 24(61.5) | 23(62.2) | 25(65.8) | 15(55.6) | 7(46.7) | ||
发病年龄( | 52.4±4.6b | 51.7±5.2b | 49.8±5.4b | 53.5±4.8b | 42.9±9.5 | 5.42a | 0.001 |
受累半规管[例(%)] | 11.34 | 0.16 | |||||
后 | 23(58.9) | 28(75.7) | 19(50.0) | 18(66.7) | 7(46.7) | ||
外 | 12(30.8) | 7(18.9) | 16(42.1) | 9(33.3) | 5(33.3) | ||
前 | 0 | 0 | 0 | 0 | 0 | ||
混合 | 4(10.3) | 2(5.4) | 3(7.9) | 0 | 3(20.0) | ||
复位次数[例(%)] | 3.60 | 0.46 | |||||
≤2次 | 28(71.8) | 26(70.3) | 26(68.4) | 17(63.0) | 7(46.7) | ||
>2次 | 11(28.2) | 11(29.7) | 12(31.6) | 10(37.0) | 8(53.3) | ||
是否一次复位即成功[例(%)] | 3.98 | 0.41 | |||||
是 | 18(46.2) | 18(48.6) | 17(44.7) | 11(40.7) | 3(20.0) | ||
否 | 21(53.8) | 19(51.4) | 21(55.3) | 16(59.3) | 12(80.0) | ||
3个月内是否复发[例(%)] | 1.903 | 0.75 | |||||
是 | 8(20.5) | 6(16.2) | 8(21.1) | 6(22.2) | 5(33.3) | ||
否 | 31(79.5) | 31(83.8) | 30(78.9) | 21(77.8) | 10(66.7) | ||
复位后是否出现残余症状[例(%)] | 1.98 | 0.74 | |||||
是 | 19(48.7) | 20(54.1) | 15(39.5) | 12(44.4) | 6(40.0) | ||
否 | 20(51.3) | 17(45.9) | 23(60.5) | 15(55.6) | 9(60.0) | ||
SAS评分( | |||||||
诊断时 | 51.05±9.43 | 47.19±9.75 | 47.61±10.46 | 47.44±11.02 | 50.73±10.58 | 1.09a | 0.36 |
4周时 | 55.95±12.78 | 53.54±11.15 | 51.97±13.32 | 53.19±13.93 | 52.20±13.50 | 0.53a | 0.71 |
3个月时 | 50.72±14.53 | 47.49±12.27 | 46.50±12.26 | 48.85±14.80 | 49.13±12.54 | 0.55a | 0.70 |
SDS评分( | |||||||
诊断时 | 55.03±11.47 | 52.84±11.92 | 53.00±13.20 | 50.52±11.60 | 52.87±12.97 | 0.55a | 0.70 |
4周时 | 58.67±14.84 | 57.32±14.34 | 54.68±14.59 | 55.15±15.51 | 54.93±12.70 | 0.49a | 0.74 |
3个月时 | 54.59±12.52 | 50.22±11.51 | 50.29±12.51 | 50.59±12.42 | 51.60±11.01 | 0.87a | 0.48 |
Table 2 Comparison of clinical characteristics of patients with different etiologies of secondary BPPV
变量 | SSNHL(n=39) | VM(n=37) | MD(n=38) | VN(n=27) | 其他(n=15) | χ2(F)值 | P值 |
---|---|---|---|---|---|---|---|
性别[例(%)] | 1.96 | 0.74 | |||||
男 | 15(38.5) | 14(37.8) | 13(34.2) | 12(44.4) | 8(53.3) | ||
女 | 24(61.5) | 23(62.2) | 25(65.8) | 15(55.6) | 7(46.7) | ||
发病年龄( | 52.4±4.6b | 51.7±5.2b | 49.8±5.4b | 53.5±4.8b | 42.9±9.5 | 5.42a | 0.001 |
受累半规管[例(%)] | 11.34 | 0.16 | |||||
后 | 23(58.9) | 28(75.7) | 19(50.0) | 18(66.7) | 7(46.7) | ||
外 | 12(30.8) | 7(18.9) | 16(42.1) | 9(33.3) | 5(33.3) | ||
前 | 0 | 0 | 0 | 0 | 0 | ||
混合 | 4(10.3) | 2(5.4) | 3(7.9) | 0 | 3(20.0) | ||
复位次数[例(%)] | 3.60 | 0.46 | |||||
≤2次 | 28(71.8) | 26(70.3) | 26(68.4) | 17(63.0) | 7(46.7) | ||
>2次 | 11(28.2) | 11(29.7) | 12(31.6) | 10(37.0) | 8(53.3) | ||
是否一次复位即成功[例(%)] | 3.98 | 0.41 | |||||
是 | 18(46.2) | 18(48.6) | 17(44.7) | 11(40.7) | 3(20.0) | ||
否 | 21(53.8) | 19(51.4) | 21(55.3) | 16(59.3) | 12(80.0) | ||
3个月内是否复发[例(%)] | 1.903 | 0.75 | |||||
是 | 8(20.5) | 6(16.2) | 8(21.1) | 6(22.2) | 5(33.3) | ||
否 | 31(79.5) | 31(83.8) | 30(78.9) | 21(77.8) | 10(66.7) | ||
复位后是否出现残余症状[例(%)] | 1.98 | 0.74 | |||||
是 | 19(48.7) | 20(54.1) | 15(39.5) | 12(44.4) | 6(40.0) | ||
否 | 20(51.3) | 17(45.9) | 23(60.5) | 15(55.6) | 9(60.0) | ||
SAS评分( | |||||||
诊断时 | 51.05±9.43 | 47.19±9.75 | 47.61±10.46 | 47.44±11.02 | 50.73±10.58 | 1.09a | 0.36 |
4周时 | 55.95±12.78 | 53.54±11.15 | 51.97±13.32 | 53.19±13.93 | 52.20±13.50 | 0.53a | 0.71 |
3个月时 | 50.72±14.53 | 47.49±12.27 | 46.50±12.26 | 48.85±14.80 | 49.13±12.54 | 0.55a | 0.70 |
SDS评分( | |||||||
诊断时 | 55.03±11.47 | 52.84±11.92 | 53.00±13.20 | 50.52±11.60 | 52.87±12.97 | 0.55a | 0.70 |
4周时 | 58.67±14.84 | 57.32±14.34 | 54.68±14.59 | 55.15±15.51 | 54.93±12.70 | 0.49a | 0.74 |
3个月时 | 54.59±12.52 | 50.22±11.51 | 50.29±12.51 | 50.59±12.42 | 51.60±11.01 | 0.87a | 0.48 |
项目 | 出现残余症状组(n=133) | 未出现残余症状组(n=207) | χ2(t)值 | P值 |
---|---|---|---|---|
性别[例(%)] | 0.11 | 0.74 | ||
男 | 49(36.8) | 80(38.6) | ||
女 | 84(63.2) | 127(61.4) | ||
年龄( | 51.9±6.2 | 52.0±6.3 | 0.06a | 0.95 |
受累半规管[例(%)] | 1.43 | 0.49 | ||
后 | 79(59.4) | 126(60.9) | ||
外 | 41(30.8) | 68(32.8) | ||
前 | 0 | 0 | ||
混合 | 13(9.8) | 13(6.3) | ||
复位次数[例(%)] | 10.32 | <0.01 | ||
≤2次 | 89(66.9) | 170(82.1) | ||
>2次 | 44(33.1) | 37(17.9) | ||
病因[例(%)] | 5.99 | 0.01 | ||
原发性 | 61(45.9) | 123(59.4) | ||
继发性 | 72(54.1) | 84(40.6) | ||
是否伴有疾病复发[例(%)] | 24.55 | <0.01 | ||
是 | 2(1.5) | 41(19.8) | ||
否 | 131(98.5) | 166(80.2) | ||
SAS评分( | ||||
诊断时 | 56.85±6.37 | 41.13±5.82 | 23.42a | <0.01 |
4周时 | 65.43±7.46 | 44.21±6.38 | 27.98a | <0.01 |
3个月时 | 58.65±12.04 | 41.14±6.61 | 15.36a | <0.01 |
SDS评分( | ||||
诊断时 | 62.71±7.22 | 44.45±5.88 | 24.42a | <0.01 |
4周时 | 69.57±7.94 | 46.15±6.91 | 28.74a | <0.01 |
3个月时 | 61.74±10.41 | 43.89±6.10 | 17.90a | <0.01 |
Table 3 Comparison of clinical features between the residual symptom group and non-residual symptom group
项目 | 出现残余症状组(n=133) | 未出现残余症状组(n=207) | χ2(t)值 | P值 |
---|---|---|---|---|
性别[例(%)] | 0.11 | 0.74 | ||
男 | 49(36.8) | 80(38.6) | ||
女 | 84(63.2) | 127(61.4) | ||
年龄( | 51.9±6.2 | 52.0±6.3 | 0.06a | 0.95 |
受累半规管[例(%)] | 1.43 | 0.49 | ||
后 | 79(59.4) | 126(60.9) | ||
外 | 41(30.8) | 68(32.8) | ||
前 | 0 | 0 | ||
混合 | 13(9.8) | 13(6.3) | ||
复位次数[例(%)] | 10.32 | <0.01 | ||
≤2次 | 89(66.9) | 170(82.1) | ||
>2次 | 44(33.1) | 37(17.9) | ||
病因[例(%)] | 5.99 | 0.01 | ||
原发性 | 61(45.9) | 123(59.4) | ||
继发性 | 72(54.1) | 84(40.6) | ||
是否伴有疾病复发[例(%)] | 24.55 | <0.01 | ||
是 | 2(1.5) | 41(19.8) | ||
否 | 131(98.5) | 166(80.2) | ||
SAS评分( | ||||
诊断时 | 56.85±6.37 | 41.13±5.82 | 23.42a | <0.01 |
4周时 | 65.43±7.46 | 44.21±6.38 | 27.98a | <0.01 |
3个月时 | 58.65±12.04 | 41.14±6.61 | 15.36a | <0.01 |
SDS评分( | ||||
诊断时 | 62.71±7.22 | 44.45±5.88 | 24.42a | <0.01 |
4周时 | 69.57±7.94 | 46.15±6.91 | 28.74a | <0.01 |
3个月时 | 61.74±10.41 | 43.89±6.10 | 17.90a | <0.01 |
变量 | 赋值 |
---|---|
残余症状发生 | 是=1,否=0 |
年龄 | 连续变量 |
受累半规管 | 后半规管=0,外半规管=1,前半规管=2,混合半规管=3 |
病因 | 原发性=0,继发性=1 |
诊断时SAS评分 | 连续变量 |
诊断时SDS评分 | 连续变量 |
Table 4 Variable assignment table for multivariate Logistic regression analysis of the influencing factors of residual symptoms after BPPV reduction
变量 | 赋值 |
---|---|
残余症状发生 | 是=1,否=0 |
年龄 | 连续变量 |
受累半规管 | 后半规管=0,外半规管=1,前半规管=2,混合半规管=3 |
病因 | 原发性=0,继发性=1 |
诊断时SAS评分 | 连续变量 |
诊断时SDS评分 | 连续变量 |
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
年龄 | 0.027 | 0.037 | 0.524 | 0.469 | 1.027(0.955~1.105) |
受累半规管 | -0.195 | 0.406 | 0.231 | 0.631 | 0.823(0.371~1.824) |
病因 | 0.555 | 0.482 | 1.322 | 0.250 | 1.741(0.677~4.482) |
诊断时SAS评分 | 0.208 | 0.050 | 17.507 | <0.001 | 1.231(1.117~1.357) |
诊断时SDS评分 | 0.190 | 0.042 | 20.102 | <0.001 | 1.209(1.113~1.314) |
Table 5 Multivariate Logistic regression analysis of the influencing factors of residual symptoms after BPPV reduction
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
年龄 | 0.027 | 0.037 | 0.524 | 0.469 | 1.027(0.955~1.105) |
受累半规管 | -0.195 | 0.406 | 0.231 | 0.631 | 0.823(0.371~1.824) |
病因 | 0.555 | 0.482 | 1.322 | 0.250 | 1.741(0.677~4.482) |
诊断时SAS评分 | 0.208 | 0.050 | 17.507 | <0.001 | 1.231(1.117~1.357) |
诊断时SDS评分 | 0.190 | 0.042 | 20.102 | <0.001 | 1.209(1.113~1.314) |
[1] |
|
[2] |
|
[3] |
孔维佳. 良性阵发性位置性眩晕诊断和治疗指南[J]. 中华耳鼻咽喉头颈外科杂志,2017,52(3):173-177.
|
[4] |
|
[5] |
|
[6] | |
[7] |
|
[8] |
|
[9] |
薛轶文,周彬,于澄,等. 老年良性阵发性位置性眩晕复发的危险因素[J]. 中国老年学杂志,2020,40(15):3261-3264. DOI:10.3969/j.issn.1005-9202.2020.15.041.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
吴子明,张素珍,周娜,等. 伴眩晕的突发性聋患者椭圆囊-球囊功能分析[J]. 听力学及言语疾病杂志,2005,13(6):397-399. DOI:10.3969/j.issn.1006-7299.2005.06.005.
|
[17] |
|
[18] |
|
[19] |
欧阳汤鹏,徐先荣,翟丽红,等. 前庭性偏头痛并发良性阵发性位置性眩晕临床特征分析[J]. 听力学及言语疾病杂志,2021,29(6):604-608. DOI:10.3969/j.issn.1006-7299.06.002.
|
[20] |
|
[21] |
王晋超,杨丽,张劲,等. 梅尼埃病合并良性阵发性位置性眩晕的眼肌前庭诱发肌源性电位研究[J]. 临床耳鼻咽喉头颈外科杂志,2021,35(2):120-124,130. DOI:10.13201/j.issn.2096-7993.2021.02.007.
|
[22] |
舒繁,张宏征,蔡洁青,等. 中耳术后继发良性阵发性位置性眩晕的临床特点及疗效分析[J]. 临床耳鼻咽喉头颈外科杂志,2020,34(1):79-82. DOI:10.13201/j.issn.1001-1781.2020.01.019.
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[1] | XIE Kexin, DU Fang, ZHANG Dan. Influencing Factors for the Effectiveness of Family Doctor Contract Services for Elderly Patients with Multimorbidity in Communities [J]. Chinese General Practice, 2024, 27(20): 2512-2519. |
[2] | LI Xingyang, SUN Wanqi, YIN Mengjie, DOU Tingting, LYU Yili, XU Wei, ZHA Zhenqiu. Sleep Quality and Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease and Their Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2024, 27(20): 2437-2444. |
[3] | HOU Nana, FENG Jinzhang, LIU Suohong, FENG Junfang, XUE Xiaoyan, YIN Na, CHI Gefu. Correlation between Serum Uric Acid/Creatinine Ratio and Metabolism-associated Fatty Liver Disease [J]. Chinese General Practice, 2024, 27(20): 2476-2482. |
[4] | GUAN Xinyue, WANG Xiaoran, ZHANG Dan. Study of Medication Adherence and Its Influencing Factors among Elderly Patients with Multimorbidity [J]. Chinese General Practice, 2024, 27(20): 2520-2526. |
[5] | LI Jing, MA Leilei, WANG Guanran, JIANG Chen, XING Haitao, YANG Hongtao. Analysis of Clinical Characteristics and Influencing Factors of Gastrointestinal Dysfunction Associated with Peritoneal Dialysis in Uremia [J]. Chinese General Practice, 2024, 27(18): 2198-2204. |
[6] | MA Guifen, ZHANG Qian, LIU Juan, SUN Jing, LIN Genlai. Risk Factors Analysis of Long-term Prognosis in Patients with D2 Radical Surgery for Stage Ⅲ Gastric Cancer after Adjuvant Chemoradiotherapy: Based on the Data of 10-year Follow-up [J]. Chinese General Practice, 2024, 27(17): 2091-2097. |
[7] | XU Su, CAI Wenwei, LI Chenyi, WANG Guanghui, XU Youduan. Current Status and Influencing Factors of Dysphagia among the Elderly in Communities: a Cross-sectional Study [J]. Chinese General Practice, 2024, 27(17): 2083-2090. |
[8] | ZHOU Lulu, LU Yuan, ZHANG Yi, GAO Xin, LIU Fang, CHENG Yuan, FENG Yuqin, YU Dehua. Analysis of Social Support and Related Factors of Family Caregivers of Patients with Mild Cognitive Impairment [J]. Chinese General Practice, 2024, 27(16): 1977-1983. |
[9] | MA Jia, ZHANG Minjue, ZHANG Shaowei, YU Haiyan, CHEN Shen, Gulibaier MAMUTI, HONG Juan, LU Yuan. Community Management of Elderly Patients with Type 2 Diabetes Complicated with Mild Cognitive Impairment Related Factors [J]. Chinese General Practice, 2024, 27(16): 1984-1989. |
[10] | ZHANG Zhao, ZHENG Tingting, WANG Yushu, LUO Fei, LIU Lei. Analysis of the Current Status and Influencing Factors of Self-management in Patients with Degenerative Spinal Deformity [J]. Chinese General Practice, 2024, 27(15): 1867-1872. |
[11] | ZHONG Ailin, LIU Ailing, ZHOU Shangcheng, GAO Sande, GAO Jing, ZOU Guanyang, CHEN Yingyao. Analysis of Knowledge-attitude-practice Behavior and Influencing Factors for Prevention of Disease in TCM in Community Residents in Guangzhou [J]. Chinese General Practice, 2024, 27(15): 1886-1892. |
[12] | ZHAI Jiayi, LU Yuan, TAO Qiongying, HUANG Wuquan, LIU Yalin, YU Dehua. A Study on the Factors Influencing Performance of Chronic Disease Management among Population with Mild Cognitive Impairment in the Context of Family Doctor Service Based on Grounded Theory [J]. Chinese General Practice, 2024, 27(13): 1608-1615. |
[13] | JIN Menglong, QIN Xiaoying, MALIYA Amiti, JIAZINI Nuerbai, LI Jianxin, CAO Jie, LUO Sifu, LIU Cheng, ZHANG Yuchen, GAI Mintao, LI Yanpeng, LU Xiangfeng, FU Zhenyan. Status and Influencing Factors of Dyslipidemia, Hypertension and Diabetes Comorbidities among Kazakhs in Xinjiang [J]. Chinese General Practice, 2024, 27(12): 1438-1444. |
[14] | SHANG Jinmeng, DENG Xiaowei. Characteristics and Risk Factors of Preserved Ratio Impaired Spirometry in Physical Examination Population [J]. Chinese General Practice, 2024, 27(11): 1331-1336. |
[15] | KANG Jing, ZHANG Ci, ZHANG Zhengyi. Distribution and Influencing Factors of Chronic Comorbidities among Middle-aged Inpatients in General Practice Department of Tertiary General Hospitals [J]. Chinese General Practice, 2024, 27(11): 1310-1315. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||